Barclays’s Oak Street Health, Inc. OSH Stock Holding History

Barclays’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,124,336	Closed	-$43.5M	–	5321
2023 Q1	$43.5M	Buy	1,124,336 +682,778	+155%	+$22M	0.02%	520
2022 Q4	$9.5M	Sell	441,558 -77,738	-15%	-$1.63M	﹤0.01%	1232
2022 Q3	$12.7M	Buy	519,296 +134,225	+35%	+$3.55M	0.01%	771
2022 Q2	$6.33M	Sell	385,071 -134,948	-26%	-$2.62M	﹤0.01%	1213
2022 Q1	$14M	Buy	+520,019	New	+$11M	0.01%	802

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Barclays's OSH Position: Q2 2023 in Review

Barclays sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 1,124,336 shares — an estimated $43.5M sold.

Barclays first reported a position in OSH in Q1 2022 and held it in 5 quarters. The position peaked at $43.5M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Barclays reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Barclays sold 1,124,336 Oak Street Health, Inc. shares in Q2 2023, an estimated $43.5M.
Barclays first reported a position in Oak Street Health, Inc. in Q1 2022 and held it in 5 quarters.
Barclays's Oak Street Health, Inc. position peaked at $43.5M in Q1 2023.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.